{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["DAMP", "Inflammation", "Lung", "SR-BI", "TLR4"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "36681128", "DateCompleted": {"Year": "2023", "Month": "02", "Day": "28"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "02"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2023", "Month": "01", "Day": "19"}], "ELocationID": ["10.1016/j.taap.2023.116381", "S0041-008X(23)00019-4"], "Journal": {"ISSN": "1096-0333", "JournalIssue": {"Volume": "462", "PubDate": {"Year": "2023", "Month": "Mar", "Day": "01"}}, "Title": "Toxicology and applied pharmacology", "ISOAbbreviation": "Toxicol Appl Pharmacol"}, "ArticleTitle": "Scavenger receptor BI attenuates oxidized phospholipid-induced pulmonary inflammation.", "Pagination": {"StartPage": "116381", "MedlinePgn": "116381"}, "Abstract": {"AbstractText": ["Damage associated molecular patterns (DAMPs) are molecules released from dead/dying cells following toxicant and/or environmental exposures that activate the immune response through binding of pattern recognition receptors (PRRs). Excessive production of DAMPs or failed clearance leads to chronic inflammation and delayed inflammation resolution. One category of DAMPs are oxidized phospholipids (oxPLs) produced upon exposure to high levels of oxidative stress, such as following ozone (O<sub>3</sub>) induced inflammation. OxPLs are bound by multiple classes of PRRs that include scavenger receptors (SRs) such as SR class B-1 (SR-BI) and toll-like receptors (TLRs). Interactions between oxPLs and PRRs appear to regulate inflammation; however, the role of SR-BI in oxPL-induced lung inflammation has not been defined. Therefore, we hypothesize that SR-BI is critical in protecting the lung from oxPL-induced pulmonary inflammation/injury. To test this hypothesis, C57BL/6J (WT) female mice were dosed with oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphatidylcholine (oxPAPC) by oropharyngeal aspiration which increased pulmonary SR-BI expression. Following oxPAPC exposure, SR-BI deficient (SR-BI<sup>-/-</sup>) mice exhibited increased lung pathology and inflammatory cytokine/chemokine production. Lipidomic analysis revealed that SR-BI<sup>-/-</sup> mice had an altered pulmonary lipidome prior to and following oxPAPC exposure, which correlated with increased oxidized phosphatidylcholines (PCs). Finally, we characterized TLR4-mediated activation of NF-\u03baB following oxPAPC exposure and discovered that SR-BI<sup>-/-</sup> mice had increased TLR4 mRNA expression in lung tissue and macrophages, increased nuclear p65, and decreased cytoplasmic I\u03baB\u03b1. Overall, we conclude that SR-BI is required for limiting oxPAPC-induced lung pathology by maintaining lipid homeostasis, reducing oxidized PCs, and attenuating TLR4-NF-\u03baB activation, thereby preventing excessive and persistent inflammation."], "CopyrightInformation": "Copyright \u00a9 2023 Elsevier Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pulmonary, Critical Care and Sleep Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States."}], "LastName": "Dunigan-Russell", "ForeName": "Katelyn", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pulmonary, Critical Care and Sleep Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States."}], "LastName": "Yaeger", "ForeName": "Michael J", "Initials": "MJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, East Carolina University, Greenville, NC, United States."}], "LastName": "Hodge", "ForeName": "Myles X", "Initials": "MX"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, East Carolina University, Greenville, NC, United States."}], "LastName": "Kilburg-Basnyat", "ForeName": "Brita", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, East Carolina University, Greenville, NC, United States."}], "LastName": "Reece", "ForeName": "Sky W", "Initials": "SW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Duke University Medical Center, Durham, NC, United States."}], "LastName": "Birukova", "ForeName": "Anastasiya", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Duke University Medical Center, Durham, NC, United States."}], "LastName": "Guttenberg", "ForeName": "Marissa A", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pulmonary, Critical Care and Sleep Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States."}], "LastName": "Novak", "ForeName": "Caymen", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pulmonary, Critical Care and Sleep Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States."}], "LastName": "Chung", "ForeName": "Sangwoon", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Deparment of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States."}], "LastName": "Ehrmann", "ForeName": "Brandie Michelle", "Initials": "BM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Deparment of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States."}], "LastName": "Wallace", "ForeName": "E Diane", "Initials": "ED"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Experimental Pathology Laboratories, Inc., Research Triangle Park, NC, United States."}], "LastName": "Tokarz", "ForeName": "Debra", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology and Pharmacology, West Virginia University, Morgantown, WV, United States."}], "LastName": "Majumder", "ForeName": "Nairrita", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Human and Health Sciences, Purdue University, West Lafayette, IN, United States."}], "LastName": "Xia", "ForeName": "Li", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pulmonary, Critical Care and Sleep Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States."}], "LastName": "Christman", "ForeName": "John W", "Initials": "JW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Human and Health Sciences, Purdue University, West Lafayette, IN, United States."}], "LastName": "Shannahan", "ForeName": "Jonathan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pulmonary, Critical Care and Sleep Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States."}], "LastName": "Ballinger", "ForeName": "Megan N", "Initials": "MN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology and Pharmacology, West Virginia University, Morgantown, WV, United States."}], "LastName": "Hussain", "ForeName": "Salik", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutrition, Gillings School of Global Public Health and School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States."}], "LastName": "Shaikh", "ForeName": "Saame Raza", "Initials": "SR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Duke University Medical Center, Durham, NC, United States."}], "LastName": "Tighe", "ForeName": "Robert M", "Initials": "RM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pulmonary, Critical Care and Sleep Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States. Electronic address: kymberly.gowdy@osumc.edu."}], "LastName": "Gowdy", "ForeName": "Kymberly M", "Initials": "KM"}], "GrantList": [{"GrantID": "P30 ES025128", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01 ES027574", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01 ES031253", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "P30 CA016058", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "R01 ES028829", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "T32 ES021432", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01 HL137224", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, U.S. Gov't, Non-P.H.S.", "Research Support, N.I.H., Extramural"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Toxicol Appl Pharmacol", "NlmUniqueID": "0416575", "ISSNLinking": "0041-008X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Carrier Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Phospholipids"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Scavenger"}, {"RegistryNumber": "0", "NameOfSubstance": "Toll-Like Receptor 4"}, {"RegistryNumber": "0", "NameOfSubstance": "Cd36 protein, mouse"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Carrier Proteins"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Inflammation"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": [], "DescriptorName": "Phospholipids"}, {"QualifierName": ["chemically induced", "prevention & control"], "DescriptorName": "Pneumonia"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Receptors, Scavenger"}, {"QualifierName": ["metabolism"], "DescriptorName": "Toll-Like Receptor 4"}], "CoiStatement": "Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Gong T, Liu L, Jiang W, Zhou R. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat Rev Immunol. 2020;20(2):95\u2013112.", "ArticleIdList": ["31558839"]}, {"Citation": "Stamenkovic A, Pierce GN, Ravandi A. Oxidized lipids: not just another brick in the wall (1). Can J Physiol Pharmacol. 2019;97(6):473\u201385.", "ArticleIdList": ["30444647"]}, {"Citation": "Minagawa S, Yoshida M, Araya J, Hara H, Imai H, Kuwano K. Regulated Necrosis in Pulmonary Disease. A Focus on Necroptosis and Ferroptosis. Am J Respir Cell Mol Biol. 2020;62(5):554\u201362.", "ArticleIdList": ["32017592"]}, {"Citation": "Ito K, Eguchi Y, Imagawa Y, Akai S, Mochizuki H, Tsujimoto Y. MPP+ induces necrostatin-1- and ferrostatin-1-sensitive necrotic death of neuronal SH-SY5Y cells. Cell Death Discov. 2017;3:17013.", "ArticleIdList": ["PMC5327502", "28250973"]}, {"Citation": "Kuwano K, Kunitake R, Kawasaki M, Nomoto Y, Hagimoto N, Nakanishi Y, et al. P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1996;154(2 Pt 1):477\u201383.", "ArticleIdList": ["8756825"]}, {"Citation": "Shlomovitz I, Erlich Z, Speir M, Zargarian S, Baram N, Engler M, et al. Necroptosis directly induces the release of full-length biologically active IL-33 in vitro and in an inflammatory disease model. FEBS J. 2019;286(3):507\u201322.", "ArticleIdList": ["30576068"]}, {"Citation": "Pouwels SD, Heijink IH, ten Hacken NH, Vandenabeele P, Krysko DV, Nawijn MC, et al. DAMPs activating innate and adaptive immune responses in COPD. Mucosal Immunol. 2014;7(2):215\u201326.", "ArticleIdList": ["24150257"]}, {"Citation": "Cao X Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease. Nat Rev Immunol. 2016;16(1):35\u201350.", "ArticleIdList": ["26711677"]}, {"Citation": "Chen GY, Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010;10(12):826\u201337.", "ArticleIdList": ["PMC3114424", "21088683"]}, {"Citation": "PrabhuDas MR, Baldwin CL, Bollyky PL, Bowdish DME, Drickamer K, Febbraio M, et al. A Consensus Definitive Classification of Scavenger Receptors and Their Roles in Health and Disease. J Immunol. 2017;198(10):3775\u201389.", "ArticleIdList": ["PMC5671342", "28483986"]}, {"Citation": "Alquraini A, El Khoury J. Scavenger receptors. Curr Biol. 2020;30(14):R790\u2013R5.", "ArticleIdList": ["PMC7768803", "32693066"]}, {"Citation": "Komai K, Shichita T, Ito M, Kanamori M, Chikuma S, Yoshimura A. Role of scavenger receptors as damage-associated molecular pattern receptors in Toll-like receptor activation. Int Immunol. 2017;29(2):59\u201370.", "ArticleIdList": ["28338748"]}, {"Citation": "Podrez EA, Poliakov E, Shen Z, Zhang R, Deng Y, Sun M, et al. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J Biol Chem. 2002;277(41):38517\u201323.", "ArticleIdList": ["12145296"]}, {"Citation": "Dahl M, Bauer AK, Arredouani M, Soininen R, Tryggvason K, Kleeberger SR, et al. Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/II. J Clin Invest. 2007;117(3):757\u201364.", "ArticleIdList": ["PMC1804372", "17332894"]}, {"Citation": "Kissick HT, Dunn LK, Ghosh S, Nechama M, Kobzik L, Arredouani MS. The scavenger receptor MARCO modulates TLR-induced responses in dendritic cells. PLoS One. 2014;9(8):e104148.", "ArticleIdList": ["PMC4121322", "25089703"]}, {"Citation": "Gao D, Ashraf MZ, Kar NS, Lin D, Sayre LM, Podrez EA. Structural basis for the recognition of oxidized phospholipids in oxidized low density lipoproteins by class B scavenger receptors CD36 and SR-BI. J Biol Chem. 2010;285(7):4447\u201354.", "ArticleIdList": ["PMC2836050", "19996318"]}, {"Citation": "Linton MF, Tao H, Linton EF, Yancey PG. SR-BI: A Multifunctional Receptor in Cholesterol Homeostasis and Atherosclerosis. Trends Endocrinol Metab. 2017;28(6):461\u201372.", "ArticleIdList": ["PMC5438771", "28259375"]}, {"Citation": "Zhang Y, Da Silva JR, Reilly M, Billheimer JT, Rothblat GH, Rader DJ. Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J Clin Invest. 2005;115(10):2870\u20134.", "ArticleIdList": ["PMC1236682", "16200214"]}, {"Citation": "Krieger M, Kozarsky K. Influence of the HDL receptor SR-BI on atherosclerosis. Curr Opin Lipidol. 1999;10(6):491\u20137.", "ArticleIdList": ["10680042"]}, {"Citation": "Landschulz KT, Pathak RK, Rigotti A, Krieger M, Hobbs HH. Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J Clin Invest. 1996;98(4):984\u201395.", "ArticleIdList": ["PMC507514", "8770871"]}, {"Citation": "Rigotti A, Acton SL, Krieger M. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem. 1995;270(27):16221\u20134.", "ArticleIdList": ["7541795"]}, {"Citation": "Santander N, Lizama C, Parga MJ, Quiroz A, Perez D, Echeverria G, et al. Deficient Vitamin E Uptake During Development Impairs Neural Tube Closure in Mice Lacking Lipoprotein Receptor SR-BI. Sci Rep. 2017;7(1):5182.", "ArticleIdList": ["PMC5507922", "28701710"]}, {"Citation": "Valacchi G, Vasu VT, Yokohama W, Corbacho AM, Phung A, Lim Y, et al. Lung vitamin E transport processes are affected by both age and environmental oxidants in mice. Toxicol Appl Pharmacol. 2007;222(2):227\u201334.", "ArticleIdList": ["PMC2770005", "17602719"]}, {"Citation": "Kolleck I, Witt W, Wissel H, Sinha P, Rustow B. HDL and vitamin E in plasma and the expression of SR-BI on lung cells during rat perinatal development. Lung. 2000;178(4):191\u2013200.", "ArticleIdList": ["10960554"]}, {"Citation": "Shen WJ, Asthana S, Kraemer FB, Azhar S. Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function. J Lipid Res. 2018;59(7):1114\u201331.", "ArticleIdList": ["PMC6027903", "29720388"]}, {"Citation": "Cai L, de Beer MC, de Beer FC, van der Westhuyzen DR. Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake. J Biol Chem. 2005;280(4):2954\u201361.", "ArticleIdList": ["15561721"]}, {"Citation": "Cai L, Wang Z, Meyer JM, Ji A, van der Westhuyzen DR. Macrophage SR-BI regulates LPS-induced pro-inflammatory signaling in mice and isolated macrophages. J Lipid Res. 2012;53(8):1472\u201381.", "ArticleIdList": ["PMC3540840", "22589557"]}, {"Citation": "Sahebi R, Hassanian SM, Ghayour-Mobarhan M, Farrokhi E, Rezayi M, Samadi S, et al. Scavenger receptor Class B type I as a potential risk stratification biomarker and therapeutic target in cardiovascular disease. J Cell Physiol. 2019;234(10):16925\u201332.", "ArticleIdList": ["30854678"]}, {"Citation": "Braun A, Trigatti BL, Post MJ, Sato K, Simons M, Edelberg JM, et al. Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res. 2002;90(3):270\u20136.", "ArticleIdList": ["11861414"]}, {"Citation": "Ueda Y, Gong E, Royer L, Cooper PN, Francone OL, Rubin EM. Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics. J Biol Chem. 2000;275(27):20368\u201373.", "ArticleIdList": ["10751392"]}, {"Citation": "Gowdy KM, Madenspacher JH, Azzam KM, Gabor KA, Janardhan KS, Aloor JJ, et al. Key role for scavenger receptor B-I in the integrative physiology of host defense during bacterial pneumonia. Mucosal Immunol. 2015;8(3):559\u201371.", "ArticleIdList": ["PMC4406784", "25336169"]}, {"Citation": "Baranova IN, Bocharov AV, Vishnyakova TG, Chen Z, Birukova AA, Ke Y, et al. Class B Scavenger Receptors BI and BII Protect against LPS-Induced Acute Lung Injury in Mice by Mediating LPS. Infect Immun. 2021;89(10):e0030121.", "ArticleIdList": ["PMC8445172", "34097506"]}, {"Citation": "Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G, et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008;133(2):235\u201349.", "ArticleIdList": ["PMC7112336", "18423196"]}, {"Citation": "Miettinen HE, Rayburn H, Krieger M. Abnormal lipoprotein metabolism and reversible female infertility in HDL receptor (SR-BI)-deficient mice. J Clin Invest. 2001;108(11):1717\u201322.", "ArticleIdList": ["PMC200987", "11733567"]}, {"Citation": "Santander NG, Contreras-Duarte S, Awad MF, Lizama C, Passalacqua I, Rigotti A, et al. Developmental abnormalities in mouse embryos lacking the HDL receptor SR-BI. Hum Mol Genet. 2013;22(6):1086\u201396.", "ArticleIdList": ["23221804"]}, {"Citation": "Aldossari AA, Shannahan JH, Podila R, Brown JM. Scavenger receptor B1 facilitates macrophage uptake of silver nanoparticles and cellular activation. Journal of Nanoparticle Research. 2015;17(7):313."}, {"Citation": "Thimmulappa RK, Gang X, Kim JH, Sussan TE, Witztum JL, Biswal S. Oxidized phospholipids impair pulmonary antibacterial defenses: evidence in mice exposed to cigarette smoke. Biochem Biophys Res Commun. 2012;426(2):253\u20139.", "ArticleIdList": ["PMC3495329", "22935414"]}, {"Citation": "Tighe RM, Birukova A, Yaeger MJ, Reece SW, Gowdy KM. Euthanasia- and Lavage-mediated Effects on Bronchoalveolar Measures of Lung Injury and Inflammation. Am J Respir Cell Mol Biol. 2018;59(2):257\u201366.", "ArticleIdList": ["PMC6096344", "29481287"]}, {"Citation": "Shannahan JH, Podila R, Aldossari AA, Emerson H, Powell BA, Ke PC, et al. Formation of a protein corona on silver nanoparticles mediates cellular toxicity via scavenger receptors. Toxicol Sci. 2015;143(1):136\u201346.", "ArticleIdList": ["PMC4274384", "25326241"]}, {"Citation": "Aldossari AA, Shannahan JH, Podila R, Brown JM Scavenger receptor B1 facilitates macrophage uptake of silver nanoparticles and cellular activation. Journal of Nanoparticle Research. 2015;17, Article number: 313."}, {"Citation": "Wang X, Katwa P, Podila R, Chen P, Ke PC, Rao AM, et al. Multi-walled carbon nanotube instillation impairs pulmonary function in C57BL/6 mice. Part Fibre Toxicol. 2011;8:24.", "ArticleIdList": ["PMC3170188", "21851604"]}, {"Citation": "Draper DW, Madenspacher JH, Dixon D, King DH, Remaley AT, Fessler MB. ATP-binding cassette transporter G1 deficiency dysregulates host defense in the lung. Am J Respir Crit Care Med. 2010;182(3):404\u201312.", "ArticleIdList": ["PMC2921600", "20395559"]}, {"Citation": "Kilburg-Basnyat B, Reece SW, Crouch MJ, Luo B, Boone AD, Yaeger M, et al. Specialized Pro-Resolving Lipid Mediators Regulate Ozone-Induced Pulmonary and Systemic Inflammation. Toxicol Sci. 2018;163(2):466\u201377.", "ArticleIdList": ["PMC5974791", "29471542"]}, {"Citation": "Van Hoecke L, Job ER, Saelens X, Roose K. Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration. J Vis Exp. 2017(123).", "ArticleIdList": ["PMC5607888", "28518083"]}, {"Citation": "Messenger ZJ, Hall JR, Jima DD, House JS, Tam HW, Tokarz DA, et al. C/EBPbeta deletion in oncogenic Ras skin tumors is a synthetic lethal event. Cell Death Dis. 2018;9(11):1054.", "ArticleIdList": ["PMC6189130", "30323292"]}, {"Citation": "Yaeger MJ, Reece SW, Kilburg-Basnyat B, Hodge MX, Pal A, Dunigan-Russell K, et al. Sex Differences in Pulmonary Eicosanoids and Specialized Pro-Resolving Mediators in Response to Ozone Exposure. Toxicol Sci. 2021;183(1):170\u201383.", "ArticleIdList": ["PMC8404991", "34175951"]}, {"Citation": "Reader BF, Sethuraman S, Hay BR, Thomas Becket RV, Karpurapu M, Chung S, et al. IRAK-M Regulates Monocyte Trafficking to the Lungs in Response to Bleomycin Challenge. J Immunol. 2020;204(10):2661\u201370.", "ArticleIdList": ["PMC7356730", "32253243"]}, {"Citation": "Chung KF, Adcock IM. Precision medicine for the discovery of treatable mechanisms in severe asthma. Allergy. 2019;74(9):1649\u201359.", "ArticleIdList": ["30865306"]}, {"Citation": "Smoak KA, Aloor JJ, Madenspacher J, Merrick BA, Collins JB, Zhu X, et al. Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation. Cell Metab. 2010;11(6):493\u2013502.", "ArticleIdList": ["PMC3091482", "20519121"]}, {"Citation": "Birukova AA, Starosta V, Tian X, Higginbotham K, Koroniak L, Berliner JA, et al. Fragmented oxidation products define barrier disruptive endothelial cell response to OxPAPC. Transl Res. 2013;161(6):495\u2013504.", "ArticleIdList": ["PMC3660521", "23305708"]}, {"Citation": "Radzikowska U, Rinaldi AO, Celebi Sozener Z, Karaguzel D, Wojcik M, Cypryk K, et al. The Influence of Dietary Fatty Acids on Immune Responses. Nutrients. 2019;11(12).", "ArticleIdList": ["PMC6950146", "31817726"]}, {"Citation": "Walton KA, Hsieh X, Gharavi N, Wang S, Wang G, Yeh M, et al. Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8. A role for Toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein. J Biol Chem. 2003;278(32):29661\u20136.", "ArticleIdList": ["12777373"]}, {"Citation": "Speen AM, Kim HH, Bauer RN, Meyer M, Gowdy KM, Fessler MB, et al. Ozone-derived Oxysterols Affect Liver X Receptor (LXR) Signaling: A POTENTIAL ROLE FOR LIPID-PROTEIN ADDUCTS. J Biol Chem. 2016;291(48):25192\u2013206.", "ArticleIdList": ["PMC5122785", "27703007"]}, {"Citation": "Lopez D, Sandhoff TW, McLean MP. Steroidogenic factor-1 mediates cyclic 3\u2032,5\u2032-adenosine monophosphate regulation of the high density lipoprotein receptor. Endocrinology. 1999;140(7):3034\u201344.", "ArticleIdList": ["10385395"]}, {"Citation": "Cao G, Garcia CK, Wyne KL, Schultz RA, Parker KL, Hobbs HH. Structure and localization of the human gene encoding SR-BI/CLA-1. Evidence for transcriptional control by steroidogenic factor 1. J Biol Chem. 1997;272(52):33068\u201376.", "ArticleIdList": ["9407090"]}, {"Citation": "Bromberg PA. Mechanisms of the acute effects of inhaled ozone in humans. Biochim Biophys Acta. 2016;1860(12):2771\u201381.", "ArticleIdList": ["27451958"]}, {"Citation": "Lockett AD, Petrusca DN, Justice MJ, Poirier C, Serban KA, Rush NI, et al. Scavenger receptor class B, type I-mediated uptake of A1AT by pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2015;309(4):L425\u201334.", "ArticleIdList": ["PMC4538232", "26092999"]}, {"Citation": "Banerjee S, de Freitas A, Friggeri A, Zmijewski JW, Liu G, Abraham E. Intracellular HMGB1 negatively regulates efferocytosis. J Immunol. 2011;187(9):4686\u201394.", "ArticleIdList": ["PMC3197890", "21957148"]}, {"Citation": "Gillotte-Taylor K, Boullier A, Witztum JL, Steinberg D, Quehenberger O. Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein. J Lipid Res. 2001;42(9):1474\u201382.", "ArticleIdList": ["11518768"]}, {"Citation": "Fessler MB. A New Frontier in Immunometabolism. Cholesterol in Lung Health and Disease. Ann Am Thorac Soc. 2017;14(Supplement_5):S399\u2013S405.", "ArticleIdList": ["PMC5711269", "29161079"]}, {"Citation": "Dai C, Yao X, Keeran KJ, Zywicke GJ, Qu X, Yu ZX, et al. Apolipoprotein A-I attenuates ovalbumin-induced neutrophilic airway inflammation via a granulocyte colony-stimulating factor-dependent mechanism. Am J Respir Cell Mol Biol. 2012;47(2):186\u201395.", "ArticleIdList": ["PMC3423466", "22427535"]}, {"Citation": "Ashraf MZ, Kar NS, Chen X, Choi J, Salomon RG, Febbraio M, et al. Specific oxidized phospholipids inhibit scavenger receptor bi-mediated selective uptake of cholesteryl esters. J Biol Chem. 2008;283(16):10408\u201314.", "ArticleIdList": ["PMC2447666", "18285332"]}, {"Citation": "Eberhart T, Eigner K, Filik Y, Fruhwurth S, Stangl H, Rohrl C. The unfolded protein response is a negative regulator of scavenger receptor class B, type I (SR-BI) expression. Biochem Biophys Res Commun. 2016;479(3):557\u201362.", "ArticleIdList": ["27666478"]}, {"Citation": "Mozzini C, Fratta Pasini A, Garbin U, Stranieri C, Pasini A, Vallerio P, et al. Increased endoplasmic reticulum stress and Nrf2 repression in peripheral blood mononuclear cells of patients with stable coronary artery disease. Free Radic Biol Med. 2014;68:178\u201385.", "ArticleIdList": ["24373961"]}, {"Citation": "Feng H, Guo L, Wang D, Gao H, Hou G, Zheng Z, et al. Deficiency of scavenger receptor BI leads to impaired lymphocyte homeostasis and autoimmune disorders in mice. Arterioscler Thromb Vasc Biol. 2011;31(11):2543\u201351.", "ArticleIdList": ["PMC3202973", "21836069"]}, {"Citation": "Urban S, Zieseniss S, Werder M, Hauser H, Budzinski R, Engelmann B. Scavenger receptor BI transfers major lipoprotein-associated phospholipids into the cells. J Biol Chem. 2000;275(43):33409\u201315.", "ArticleIdList": ["10938082"]}, {"Citation": "Harizi H, Corcuff JB, Gualde N. Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends Mol Med. 2008;14(10):461\u20139.", "ArticleIdList": ["18774339"]}, {"Citation": "Pascoe CD, Roy N, Turner-Brannen E, Schultz A, Vaghasiya J, Ravandi A, et al. Oxidized phosphatidylcholines induce multiple functional defects in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2021;321(4):L703\u2013L17.", "ArticleIdList": ["34346781"]}, {"Citation": "Fruhwirth GO, Moumtzi A, Loidl A, Ingolic E, Hermetter A. The oxidized phospholipids POVPC and PGPC inhibit growth and induce apoptosis in vascular smooth muscle cells. Biochim Biophys Acta. 2006;1761(9):1060\u20139.", "ArticleIdList": ["16904371"]}, {"Citation": "Que X, Hung MY, Yeang C, Gonen A, Prohaska TA, Sun X, et al. Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice. Nature. 2018;558(7709):301\u20136.", "ArticleIdList": ["PMC6033669", "29875409"]}, {"Citation": "Kadl A, Sharma PR, Chen W, Agrawal R, Meher AK, Rudraiah S, et al. Oxidized phospholipid-induced inflammation is mediated by Toll-like receptor 2. Free Radic Biol Med. 2011;51(10):1903\u20139.", "ArticleIdList": ["PMC3197756", "21925592"]}, {"Citation": "Guo L, Song Z, Li M, Wu Q, Wang D, Feng H, et al. Scavenger Receptor BI Protects against Septic Death through Its Role in Modulating Inflammatory Response. J Biol Chem. 2009;284(30):19826\u201334.", "ArticleIdList": ["PMC2740408", "19491399"]}, {"Citation": "Taront S, Dieudonne A, Blanchard S, Jeannin P, Lassalle P, Delneste Y, et al. Implication of scavenger receptors in the interactions between diesel exhaust particles and immature or mature dendritic cells. Part Fibre Toxicol. 2009;6:9.", "ArticleIdList": ["PMC2657891", "19284653"]}, {"Citation": "Van Eck M, Hoekstra M, Hildebrand RB, Yaong Y, Stengel D, Kruijt JK, et al. Increased oxidative stress in scavenger receptor BI knockout mice with dysfunctional HDL. Arterioscler Thromb Vasc Biol. 2007;27(11):2413\u20139.", "ArticleIdList": ["17717299"]}, {"Citation": "Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, Krieger M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci U S A. 1997;94(23):12610\u20135.", "ArticleIdList": ["PMC25055", "9356497"]}, {"Citation": "Helgadottir A, Sulem P, Thorgeirsson G, Gretarsdottir S, Thorleifsson G, Jensson BO, et al. Rare SCARB1 mutations associate with high-density lipoprotein cholesterol but not with coronary artery disease. Eur Heart J. 2018;39(23):2172\u20138.", "ArticleIdList": ["PMC6001888", "29596577"]}, {"Citation": "Vickers KC, Rodriguez A. Human scavenger receptor class B type I variants, lipid traits, and cardiovascular disease. Circ Cardiovasc Genet. 2014;7(6):735\u20137.", "ArticleIdList": ["PMC4373599", "25516621"]}, {"Citation": "Zanoni P, Khetarpal SA, Larach DB, Hancock-Cerutti WF, Millar JS, Cuchel M, et al. Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease. Science. 2016;351(6278):1166\u201371.", "ArticleIdList": ["PMC4889017", "26965621"]}, {"Citation": "Vergeer M, Korporaal SJ, Franssen R, Meurs I, Out R, Hovingh GK, et al. Genetic variant of the scavenger receptor BI in humans. N Engl J Med. 2011;364(2):136\u201345.", "ArticleIdList": ["21226579"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "10", "Day": "15"}, {"Year": "2022", "Month": "12", "Day": "30"}, {"Year": "2023", "Month": "1", "Day": "11"}, {"Year": "2023", "Month": "1", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "21", "Hour": "19", "Minute": "23"}, {"Year": "2024", "Month": "3", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36681128", "NIHMS1874811", "PMC9983330", "10.1016/j.taap.2023.116381", "S0041-008X(23)00019-4"]}}], "PubmedBookArticle": []}